Table 1.

Participant demographic and baseline characteristics by site and by treatment group

	Site A	Site B	Site C	Site D	Site Analysis	TAU	MET	Group Analysis
	N=61	N=74	N=55	N=10	X2 or F	N=98	N=102	X2 or t
Age (Years)	23.9 (5.0)	27.9 (5.7)	26.6 (4.1)	25.9 (6.8)	10.67**	25.1 (4.8)	27.3 (5.8)	3.02**
Race/Ethnicity (%)+					20.53**			3.85*
African-American	39.7	54.4	0.0	55.6		31.1	38.1
Caucasian	56.9	44.1	15.4	33.3		46.7	33.0
Hispanic	1.7	1.5	65.4	11.1		14.4	24.7
Other	1.7	0.0	19.2	0.0		7.8	4.1
Marital Status (%)					13.53**			0.52
Married	1.6	14.9	23.6	40.0		16.3	12.7
Separated/Divorced	18.0	18.9	10.9	0.0		15.3	15.7
Not Married	80.3	66.2	65.5	60.0		68.4	71.6
Education (Years)	11.7 (1.5)	11.2 (1.8)	11.7 (1.7)	10.7 (2.4)	1.58	11.2 (1.4)	11.7 (1.9)	2.33*
Employed Full/Part time (%)	29.5	20.3	25.5	20.0	1.55	27.6	21.6	0.97
Weeks Pregnant	19.1 (7.5)	23.0 (7.8)	19.1 (7.3)	14.9 (7.7)	6.01**	19.9 (7.5)	20.7 (8.2)	0.74
Primary drug used (%)
Alcohol	11.5	6.8	10.9	30.0	1.05	11.2	9.8	0.11
Cocaine	8.2	33.8	21.8	50.0	12.72**	17.3	29.4	4.05*
Marijuana	65.6	21.6	7.3	20.0	51.06**	37.8	24.5	4.10*
Opiates	8.2	4.1	32.7	0.0	24.25**	12.2	13.7	0.10
Methamphetamine	4.9	4.1	16.4	0.0	7.67*	6.1	8.8	0.53
Benzodiazepines	1.6	1.4	0.0	0.0	0.85	1.0	1.0	0.00
Other	0.0	28.4	10.9	0.0	22.78**	14.3	12.7	0.10
Days of use (past 28)	8.0 (10.8)	6.7 (9.1)	16.0 (12.4)	6.0 (8.5)	13.23**	9.0 (10.9)	10.2 (11.5)	0.44
Need methadone (%)	1.6	2.7	40.0	0.0	48.84**	12.2	12.7	0.01
Pressure to attend treatment (%)	23.0	24.3	1.8	20.0	13.08**	22.4	12.7	3.26

Note. Where not specifically indicated, numbers represent means (standard deviations).

⁺Comparisons are for Caucasian to minority participants.

^*p<.05

^**p<.01.